Causes, outcome and prevention of abandonment in retinoblastoma in India

Pediatric Blood and Cancer

Volumn 60, Issue 5, 2013, Pages 771-775

  Kumar, Archana ^a   Moulik, Nirmalya Roy ^a   Mishra, Ravi Krishna ^a   Kumar, Dipak ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Abandonment; Developing country; Non compliance; Retinoblastoma

Indexed keywords

CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER REGISTRY; CANCER SURGERY; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRYOTHERAPY; DEMOGRAPHY; ENUCLEATION; FEAR; FEMALE; HEALTH CARE COST; HUMAN; INDIA; INFANT; LASER COAGULATION; LASER THERMOTHERAPY; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT ABANDONMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; POSTAL MAIL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETREATMENT; RETROSPECTIVE STUDY; SCHOOL CHILD; SPIRITUAL HEALING; SUPERSTITION; TELEPHONE; TREATMENT REFUSAL;

CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DEVELOPING COUNTRIES; EYE ENUCLEATION; FEMALE; HUMANS; INDIA; INFANT; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 84874983435     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24454     Document Type: Article

References (16)

1. Chantada GL, Qaddoumi I, Canturk S, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer 2011; 56: 341-348.
2. Boubacar T, Fatou S, Fousseyni T, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure teaching hospital, Bamako, Mali. Br J Ophthalmol 2010; 94: 467-469.
3. Gallie BL, Zhao J, Vandezande K, et al. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer 2007; 49: 1083-1090.
4. Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: One world, one vision. Pediatrics 2008; 122: e763-e770.
5. Bakhshi S, Gupta S, Gogia V, et al. Compliance in retinoblastoma. Indian J Pediatr 2010; 77: 535-540.
6. Al-Obaid JA, Al-Megbel Y. Factors influencing retinoblastoma patients/siblings compliance with clinic appointments. Saudi Med J 2006; 27: 1561-1566.
7. Kumar N, Shekhar C, Kumar P, et al. Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr 2007; 74: 1131-1132.
8. Pratt CB, Fontanesi J, Lu X, et al. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist 1997; 2: 1-5.
9. Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In Pizzo PA, Poplack DG, editors. Principles and practice of paediatric oncology, 6th edition. Philadelphia: Lippincott Williams and Wilkins; 2011. pp 809-837.
10. Sitorus RS, Moll AC, Suhardjono S, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet 2009; 30: 31-36.
11. Leander C, Fu LC, Peña A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007; 49: 817-819.
12. Bishop FL, Prescott P, Chan YK, et al. Prevalence of complementary medicine use in paediatric cancer: A systematic review. Pediatrics 2010; 125: 768-776.
13. Spinetta JJ, Masera G, Eden T, et al. Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: A report of the SIOP Working Committee on Psychosocial Issues in Paediatric Oncology. Med Pediatr Oncol 2002; 38: 114-117.
14. Hord JD, Rehman W, Hannon P, et al. Do parents have the right to refuse standard treatment for their child with favorable-prognosis cancer? Ethical and legal concerns. J Clin Oncol 2006; 24: 5454-5456.
15. Beauchamp T, Childress J. Principles of biomedical ethics, 5th edition. New York, NY: Oxford University Press; 2001.
16. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009; 53: 42-46.